Weiss Kellie K, Chen Renxiang, Skasko Mark, Reynolds Holly M, Lee Kwi, Bambara Robert A, Mansky Louis M, Kim Baek
Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 672, Rochester, New York 14642, USA.
Biochemistry. 2004 Apr 20;43(15):4490-500. doi: 10.1021/bi035258r.
HIV-1 reverse transcriptase (RT) is a highly error prone DNA polymerase. We assessed whether the ability of RT to bind nucleotide substrates affects viral mutagenesis. Structural modeling predicts that the V148 and Q151 residues influence the interaction between RT and the incoming dNTP. When we introduce either a V148I or Q151N mutation, RT fidelity increases 8.7- or 13-fold, respectively, as measured by the M13 lacZalpha forward mutation assay. Interestingly, pre-steady state kinetic studies demonstrated that these mutations do not alter polymerase fidelity during the first step of mutation synthesis, misincorporation. Rather, the V148I and Q151N mutations alter RT fidelity by weakening the ability of the polymerase to complete mismatch extension, the second step of mutation synthesis. While both these mutations minimally affect the binding of RT (K(D)) to a mismatched template-primer complex (T/P), these mutant RTs are significantly impaired in their ability to bind (K(d)) and chemically incorporate (k(pol)) nucleotide substrate onto a mismatched T/P. These differences in binding and catalysis translate into 24- and 15.9-fold increase in mismatch extension fidelity for the V148I and Q151N RT mutants, respectively. Finally, we employed a cell-based pseudotyped HIV-1 mutation assay to determine whether changes in these dNTP binding residues alter RT fidelity in vivo. We found that the V148I and Q151N mutant viruses had 3.8- and 5.7-fold higher fidelities than wild-type viruses, respectively, indicating that the molecular interaction between HIV-1 RT and the dNTP substrate contributes to viral mutagenesis.
HIV-1逆转录酶(RT)是一种极易出错的DNA聚合酶。我们评估了RT结合核苷酸底物的能力是否会影响病毒的诱变作用。结构建模预测,V148和Q151残基会影响RT与进入的脱氧核苷三磷酸(dNTP)之间的相互作用。当我们引入V148I或Q151N突变时,通过M13 lacZα正向突变试验测定,RT保真度分别提高了8.7倍或13倍。有趣的是,稳态前动力学研究表明,这些突变在突变合成的第一步即错配掺入过程中不会改变聚合酶保真度。相反,V148I和Q151N突变通过削弱聚合酶完成错配延伸(突变合成的第二步)的能力来改变RT保真度。虽然这两种突变对RT(K(D))与错配模板-引物复合物(T/P)的结合影响最小,但这些突变型RT在结合(K(d))和将核苷酸底物化学掺入(k(pol))到错配T/P上的能力上显著受损。结合和催化方面的这些差异分别导致V148I和Q151N RT突变体的错配延伸保真度提高了24倍和15.9倍。最后,我们采用基于细胞的假型HIV-1突变试验来确定这些dNTP结合残基的变化是否会在体内改变RT保真度。我们发现,V148I和Q151N突变病毒的保真度分别比野生型病毒高3.8倍和5.7倍,这表明HIV-1 RT与dNTP底物之间的分子相互作用有助于病毒诱变。